Abstract
The role of nitric oxide (NO) in the response to Photofrin-based photodynamic therapy (PDT) was investigated using mouse tumour models characterized by either relatively high or low endogenous NO production (RIF and SCCVII vs EMT6 and FsaR, respectively). The NO synthase inhibitors Nω-nitro- L -arginine (L-NNA) or Nω-nitro- L -arginine methyl ester (L-NAME), administered to mice immediately after PDT light treatment of subcutaneously growing tumours, markedly enhanced the cure rate of RIF and SCCVII models, but produced no obvious benefit with the EMT6 and FsaR models. Laser Doppler flowmetry measurement revealed that both L-NNA and L-NAME strongly inhibit blood flow in RIF and SCCVII tumours, but not in EMT6 and FsaR tumours. When injected intravenously immediately after PDT light treatment, L-NAME dramatically augmented the decrease in blood flow in SCCVII tumours induced by PDT. The pattern of blood flow alterations in tumours following PDT indicates that, even with curative doses, regular circulation may be restored in some vessels after episodes of partial or complete obstruction. Such conditions are conducive to the induction of ischaemia-reperfusion injury, which is instigated by the formation of superoxide radical. The administration of superoxide dismutase immediately after PDT resulted in a decrease in tumour cure rates, thus confirming the involvement of superoxide in the anti-tumour effect. The results of this study demonstrate that NO participates in the events associated with PDT-mediated tumour destruction, particularly in the vascular response that is of critical importance for the curative outcome of this therapy. The level of endogenous production of NO in tumours appears to be one of the determinants of sensitivity to PDT. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Andrade SP, Hart IR and Piper PJ (1992) Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 107: 1092–1095
Athar M, Mukhtar H, Elmets CA, Zaim MT, Lloyd JR and Bickers DR (1988) In situ evidence for the involvement of superoxide anions in cutaneous porphyrin photosensitization. Biochem Biophys Res Commun 151: 1054–1059
Athar M, Elmets CA, Bickers DR and Mukhtar H (1989) A novel mechanism for the generation of superoxide anions in hematoporphyrin derivative-mediated cutaneous photosensitization. Activation of xanthine oxidase pathway. J Clin Invest 83: 1137–1143
Beckman JS, Beckman TW, Chen J, Marshall PA and Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad SCI USA 87: 1620–1624
Blough NV and Zafiriou OC (1985) Reaction of superoxide with nitric oxide to form peroxynitrate in alkaline aqueous solution. Inorganic Chemistry 24: 3504–3505
Bredt DS and Synder SH (1994) Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63: 175–195
Cecic I and Korbelik M (1999) Neutrophil-associated events in the inflammation of cancerous tissue following treatment with photodynamic therapy. Trends in Photochemistry and Photobiology 6: 53–61
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J and Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90: 889–905
Durand RE and LePard NE (1994) Modulation of tumour hypoxia by conventional chemotherapeutic agents. Int J Radiat Oncol Biol Phys 29: 481–486
Evans TJ, Buttery LDK, Carpenter A, Springall DR, Polak JM and Cohen J (1996) Cytokine-treated human neutrophils contain inducible nitric oxide synthase that produces nitration of ingested bacteria. Proc Natl Acad Sci USA 93: 9553–9558
Fukumura D and Jain RK (1998) Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev 17: 77–89
Gaboury JP, Anderson DC and Kubes P (1994) Molecular mechanisms involved in superoxide-induced leukocyte–endothelial cell interactions in vivo. Am J Physiol 266: H637–H642
Gilissen MJ, van de Merbel-de Wit LE, Star WM, Koster JF and Sluiter W (1993) Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. Cancer Res 53: 2548–2552
Gollnick SO, Liu X, Owczarczak B, Musser DA and Henderson BW (1997) Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 57: 3904–3909
Grisham MB, Hernandez LA and Granger DN (1986) Xanthine oxidase and neutrophil infiltration in intestinal ischaemia. Am J Physiol 251: G567–G574
Gupta S, Ahmad N and Mukhtar H (1998) Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res 58: 1785–1788
Hirst DG and Flitney FW (1997) The physiological importance and therapeutic potential of nitric oxide in tumour-associated vasculature. Tumour Angiogenesis, Bicknell R, Lewis CE, Ferrara N153–167, Oxford University Press: Oxford
Henderson BW, Sitnik-Busch TM and Vaughan LA (1999) Potentiation of photodynamic therapy anti tumour activity in mice by nitric oxide synthase inhibition is fluence rate dependent. Photochem Photobiol 70: 64–71
Horsman MR, Chaplin DJ, Hill SA, Arnold S, Collingridge D, Radacic M, Wood PJ and Overgaard J (1996) Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours. Br J Cancer 74: S168–S171
Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S (1995) Roles of nitric oxide in tumour growth. Proc Natl Acad Sci USA 92: 4392–4396
Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K and Dewhirst MW (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56: 5522–5528
Korbelik M, Cecic I and Shibuya H (1997) The role of nitric oxide in the response of cancerous lesions to photodynamic therapy. Recent Research Developments in Photochemistry & Photobiology 1: 267–276
Korbelik M and Krosl G (1996a) Photofrin accumulation in malignant and host cell populations of various tumours. Br J Cancer 73: 506–513
Korbelik M and Krosl G (1996b) Photosensitizer distribution and photosensitized damage of tumour tissues. The Fundamental Bases of Phototherapy, Hönigsman H, Jori G, Yang AR229–245, OEMF spa: Milan
Korbelik M and Cecic I (1998) Enhancement of tumour response to photodynamic therapy by adjuvant mycobacterium cell-wall treatment. J Photochem Photobiol B: Biol 44: 151–158
Korbelik M, Shibuya H and Cecic I (1998) Relevance of nitric oxide to the response of tumors to photodynamic therapy. Proceedings of SPIE – The International Society for Optical Engineering 3247: 98–105
Krosl G, Korbelik M and Dougherty GJ (1995) Induction of immune cell infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy. Br J Cancer 71: 549–555
Kubes P, Suzuki M and Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88: 4651–4655
Lala PK and Orucevic A (1998) Role of nitric oxide in tumor progression: lessons from experimental tumors. Cancer Metastasis Rev 17: 91–106
McCall TB, Boughton-Smith NK, Palmer RM, Whittle BJ and Moncada S (1989) Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem J 261: 293–296
Mehta JL, Lawson DL, Nicolini FA, Ross MH and Player DW (1991) Effects of activated polymorphonuclear leukocytes on vascular smooth muscle tone. Am J Physiol 261: H327–H334
Moilanen E, Vuorinen P, Kankaanranta H, Metsä-Ketelä T and Vapaatalo H (1993) Inhibition by nitric oxide-donors of human polymorphonuclear leucocyte functions. Br J Pharmacol 109: 852–858
Moulder JE and Rockwell S (1984) Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 10: 695–712
Moulder JE and Rockwell S (1987) Tumor hypoxia: its impact on cancer therapy. Cancer Metastasis Rev 5: 313–341
Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T and Inoue M (1991) Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci USA 88: 10045–10048
Ochsner M (1997) Photophysical and photobiological processes in the photodynamic therapy of tumours. Journal of Photochemistry and Photobiology B: Biology 39: 1–18
Orucevic A, Bechberger J, Green AM, Shapiro RA, Billiar TR and Lala PK (1999) Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness. Int J Cancer 81: 889–896
Parkins CS, Dennis MF, Stratford MRL, Hill SA and Chaplin DJ (1995) Ischemia reperfusion injury in tumors: the role of oxygen radicals and nitric oxide. Cancer Res 55: 6026–6029
Parkins CS, Hill SA, Stratford MR, Dennis MF and Chaplin DJ (1997) Metabolic and clonogenic consequences of ischaemia reperfusion insult in solid tumours. Exp Physiol 82: 361–368
Parkins CS, Holder AL, Dennis MF, Stratford MR and Chaplin DJ (1998) Involvement of oxygen free radicals in ischaemia-reperfusion injury to murine tumours: role of nitric oxide. Free Radic Res 28: 271–281
Rees DD, Cunha FQ, Assreuy J, Herman AG and Moncada S (1995) Sequential induction of nitric oxide synthase by Corynebacterium parvum in different organs of the mouse. Br J Pharmacol 114: 689–693
Rockwell SC, Kallman RF and Fajardo LF (1972) Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst 49: 735–749
Schmidt HHH and Walter U (1994) NO at work. Cell 78: 919–925
Schulz R and Wambolt R (1995) Inhibition of nitric oxide synthesis protects the isolated working rabbit heart from ischaemia-reperfusion injury. Cardiovasc Res 30: 432–439
Shepherd AP, Riedel GL, Kiel JW, Haumschild DJ and Maxwell LC (1987) Evaluation of an infrared laser Doppler blood flowmeter. Am J Physiol 252: G832–G839
Stratford MRL, Dennis MF, Cochrane R, Parkins CS and Everett SA (1997) The role of nitric oxide in cancer: improved methods for measurement of nitrite and nitrate by high-performance ion chromatography. J Chromatogr 770: 151–155
Suit HD, Sedlacek RS, Silver G and Dosoretz D (1985) Pentobarbital anesthesia and response of tumor and normal tissue in the C3Hf/Sed mouse to radiation. Radiat Res 104: 47–65
Tozer GM and Everett SA (1997a) Nitric oxide in tumour biology and cancer therapy. Part 2: therapeutic implications. Clin Oncol 9: 357–364
Tozer GM and Everett SA (1997b) Nitric oxide in tumour biology and cancer therapy. Part 1: physiological aspects. Clin Oncol 9: 282–293
Twentyman PR, Brown JM, Gray JW, Franko AJ, Scoles MA and Kallman RF (1980) A new mouse tumor model system (RIF-1) for comparison of end-point studies. J Natl Cancer Inst 64: 595–604
van Geel IPJ, Oppelaar H, Oussoren YG and Stewart FA (1994) Changes in perfusion of mouse tumours after photodynamic therapy. Int J Cancer 56: 224–228
van Geel IPJ, Oppelaar H, Rijken PFJW, Bernsen HJJA, Hagemeier NEM, van der Kogel AJ, Hodgkiss RJ and Stewart FA (1996) Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. Br J Cancer 73: 288–293
Vanhoutte PM (1987) Endothelium and responsiveness of vascular smooth muscle. J Hypertens Suppl 5: S115–S120
Volpe JP, Hunter N, Basic I and Milas L (1985) Metastatic properties of murine sarcomas and carcinomas. I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take. Clin Exp Metastasis 3: 281–294
Wolin MS (1996) Reactive oxygen species and vascular signal transduction mechanisms. Microcirculation 3: 1–17
Wood PJ, Sansom JM, Butler SA, Stratford IJ, Cole SM, Szabo C, Thiemerman C and Adams GE (1994) Induction of hypoxia in experimental murine tumors by the nitric oxide synthase inhibitor, NG-nitro-L-arginine. Cancer Res 54: 6458–6463
Xie K, Huang S, Dong Z, Gutman M and Fidler IJ (1995) Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. Cancer Res 55: 3123–3131
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Korbelik, M., Parkins, C., Shibuya, H. et al. Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br J Cancer 82, 1835–1843 (2000). https://doi.org/10.1054/bjoc.2000.1157
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1157
Keywords
This article is cited by
-
Nitric Oxide Inhibition of Chain Lipid Peroxidation Initiated by Photodynamic Action in Membrane Environments
Cell Biochemistry and Biophysics (2020)
-
Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours
British Journal of Cancer (2003)